Adding bevacizumab may not improve breast cancer survival
1. In a phase III trial of over 370 patients with advanced breast cancer, the addition of anti-vascular endothelial growth...
Monica graduated from University of California, Berkeley in 2012 with a degree in Integrative Biology. She is currently in her 4th year of medical school at the University of California, San Francisco School of Medicine. She is interested in medical education, curriculum development, and health advocacy for underserved populations. Next year, she hopes to begin residency, and is considering future training in hematology/oncology or pulmonary and critical care medicine. Disclosures: Member, American Medical Association; Member, American College of Obstetrics & Gynecology
1. In a phase III trial of over 370 patients with advanced breast cancer, the addition of anti-vascular endothelial growth...
1. In a prospective cohort of over 2,500 patients diagnosed with non-metastatic colorectal cancer, post-diagnosis active smoking was associated with...
1. In a retrospective review of over 600 patients with ovarian cancer, preoperative disease burden was the single most significant...
1. In a phase II trial of 35 women with advanced endometrial cancer, combination therapy with aromatase inhibitor (letrozole) and...
1. In a prospective cohort of over 400 children with acute lymphoblastic leukemia treated with chemotherapy, hip MRI have high...
1. In a phase II trial of 90 patients with metastatic pancreatic adenocarcinoma, the combination of two cancer vaccines, Cy/GVAX...
1. In a retrospective review of over 700 childhood cancer survivors (CCS) treated with cranial radiotherapy, over 50% developed anterior...
1. In a phase III trial of over 700 patients with hepatocellular carcinoma (HCC), there was no significant difference in...
1. In a cohort of more than 20 000 breast cancer patients followed for a median of 5 years, the...
1. In a cohort of more than 900 low-risk prostate cancer patients followed for up to 15 years, 2.8% of...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.